DoW Neurofibromatosis Exploration-Hypothesis Development Award
Agency: Defense Health Agency Contracting Activity - DHACA
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Distinctive Features:
• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.
• Preliminary Data: Preliminary and/or published data is encouraged but not required.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
eBRAP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| HT042526NFRPEHDA_GG.pdf | FY26 NFRP EHDA Program Announcement | Jun 25, 2026 08:31 PM UTC |
Link to additional information
--
Closing: September 22, 2026
Award
$1,280,000
Program Funding
8
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
HT942526NFRPEHDA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Posted date:
June 25, 2026
Archive date:
October 22, 2026
